Philochem AG

The core activity of Philochem is the development and research of bioactive compounds for cancer treatment, particularly in the areas of Target Discovery, Ligand Discovery and small molecule therapeutics. The company focuses on developing compounds that target the site of the disease while protecting healthy tissue. The company's products include various radiopharmaceuticals for imaging and therapy of cancer, such as 68Ga-OncoFAP, 177Lu-OncoFAP and 68Ga-OncoCAIX.